Yantai Zhenghai Bio-Tech Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 56.48%

Yantai Zhenghai Bio-Tech Co Ltd (300653) has an Asset Resilience Ratio of 56.48% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Yantai Zhenghai Bio-Tech Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥544.95 Million

≈ $79.74 Million USD Cash + Short-term Investments

Total Assets

CN¥964.85 Million

≈ $141.19 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Yantai Zhenghai Bio-Tech Co Ltd's Asset Resilience Ratio has changed over time. See 300653 net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Yantai Zhenghai Bio-Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Yantai Zhenghai Bio-Tech Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥544.95 Million	56.48%
Total Liquid Assets	CN¥544.95 Million	56.48%

Asset Resilience Insights

Very High Liquidity: Yantai Zhenghai Bio-Tech Co Ltd maintains exceptional liquid asset reserves at 56.48% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Yantai Zhenghai Bio-Tech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Yantai Zhenghai Bio-Tech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	25.67%
Tubize-Fin BR:TUB	Biotechnology	0.05%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
Dashenlin Pharm Grp Co Ltd SHG:603233	Biotechnology	0.02%
Staidson Beijing Biopharma SHE:300204	Biotechnology	7.93%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	41.25%
Ardelyx Inc NASDAQ:ARDX	Biotechnology	41.14%
Xiangxue Pharmaceutical SHE:300147	Biotechnology	0.05%

Annual Asset Resilience Ratio for Yantai Zhenghai Bio-Tech Co Ltd (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Yantai Zhenghai Bio-Tech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	51.57%	CN¥505.43 Million ≈ $73.96 Million	CN¥980.11 Million ≈ $143.42 Million	-5.24pp
2023-12-31	56.80%	CN¥598.61 Million ≈ $87.60 Million	CN¥1.05 Billion ≈ $154.21 Million	+2.67pp
2022-12-31	54.13%	CN¥534.21 Million ≈ $78.17 Million	CN¥986.90 Million ≈ $144.42 Million	+6.20pp
2021-12-31	47.92%	CN¥445.18 Million ≈ $65.14 Million	CN¥928.92 Million ≈ $135.93 Million	+16.70pp
2020-12-31	31.23%	CN¥251.55 Million ≈ $36.81 Million	CN¥805.54 Million ≈ $117.88 Million	-20.89pp
2019-12-31	52.12%	CN¥375.48 Million ≈ $54.94 Million	CN¥720.45 Million ≈ $105.42 Million	--

pp = percentage points

About Yantai Zhenghai Bio-Tech Co Ltd

SHE:300653 China Biotechnology

Market Cap

$483.33 Million

CN¥3.30 Billion CNY

Market Cap Rank

#12706 Global

#3966 in China

Share Price

CN¥18.35

Change (1 day)

-1.45%

52-Week Range

CN¥18.05 - CN¥23.13

All Time High

CN¥53.33